1
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Congestive heart failure in the elderly

The therapeutic challenge of atypical presentations

Pages 83-87 | Published online: 17 May 2016

Reference

  • Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985: 55(2): 3–8A
  • McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971: 285(26): 1441–6
  • Smith TW. Digitalis: mechanisms of action and clinical use. N Engl J Med 1988: 318(6): 358–65
  • The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with Captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988: 259(4): 539–44
  • Cohn JN, Archibald DG, Zeische S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study. N Engl J Med 1986: 314(24): 1547–52
  • The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987: 316(23): 1429–35
  • Gheorghiade M, Hall V, Lakier JB, et al. Comparative hemodynamic and neurohormonal effects of intravenous Captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 1989: 13(1): 134–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.